Financials data is unavailable for this security.
View more
Year on year Amedisys Inc had net income fall from a gain of 118.61m to a loss of 9.75m despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 33.92% to 34.88%.
| Gross margin | 44.03% |
|---|---|
| Net profit margin | 4.01% |
| Operating margin | 6.99% |
| Return on assets | 4.48% |
|---|---|
| Return on equity | 8.63% |
| Return on investment | 6.02% |
More ▼
Cash flow in USDView more
In 2023, Amedisys Inc increased its cash reserves by 156.52%, or 84.73m. The company earned 137.19m from its operations for a Cash Flow Margin of 6.13%. In addition the company generated 35.06m cash from investing, though they paid out 87.52m more in financing than they received.
| Cash flow per share | 3.54 |
|---|---|
| Price/Cash flow per share | 27.36 |
| Book value per share | 34.37 |
|---|---|
| Tangible book value per share | -6.73 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.16 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.3459 |
|---|---|
| Total debt/total capital | 0.2482 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -108.23%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 3,934.69 |
